Swati Tole’s drug development experience spans a wide range of disease areas in adults and children, including rheumatology, gastroenterology, hepatology, and infectious disease. Prior to joining Capsida, Dr. Tole spent 13 years at Genentech in roles of increasing responsibility, most recently as Vice President of Clinical Development. In this role, Dr. Tole oversaw and advised teams working on several molecules across the gastroenterology and hepatology space.
Dr. Tole holds an M.D. from the University of California San Francisco, an M.S. in health services research from Stanford University, and a B.S. in biology from Stanford University. She completed her residency in internal medicine and chief residency at UCSF, and her fellowship in health economics and outcomes research at Stanford University.